GMED logo

GMED
Globus Medical Inc

1,579
Mkt Cap
$10.53B
Volume
6.04M
52W High
$101.40
52W Low
$51.79
PE Ratio
18.15
GMED Fundamentals
Price
$77.95
Prev Close
$85.07
Open
$85.55
50D MA
$89.45
Beta
0.98
Avg. Volume
1.01M
EPS (Annual)
$3.92
P/B
2.23
Rev/Employee
$489,821.83
$11,528.56
Loading...
Loading...
News
all
press releases
Oversold Conditions For Globus Medical (GMED)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...
Nasdaq News: Markets·1d ago
News Placeholder
More News
News Placeholder
GMED Stock Rises on Q1 Earnings & Revenue Beat, '26 EPS View Raised
Globus Medical beats Q1 EPS estimates by 22% as revenues rise 27% to $759.9M; margins widen and 2026 EPS outlook up, lifting shares 5.8%.
Zacks·1d ago
News Placeholder
Globus Medical (GMED) Tops Q1 Earnings and Revenue Estimates
Globus Medical (GMED) delivered earnings and revenue surprises of +22.07% and +4.04%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2d ago
News Placeholder
Compared to Estimates, Globus Medical (GMED) Q1 Earnings: A Look at Key Metrics
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·2d ago
News Placeholder
Globus Medical (GMED) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·2d ago
News Placeholder
IONQ Stock Falls on Q1 Earnings Miss, Revenues Beat, '26 Sales View Up
IonQ beats revenue estimates on surging commercial sales but posts a wider adjusted loss, sending shares down after hours.
Zacks·2d ago
News Placeholder
TEM Q1 Loss Narrower Than Expected, Revenues Beat, Stock Down
Tempus AI posts narrower Q1 loss and strong 36% revenue growth, but shares slide after-market as operating loss and rising costs weigh on sentiment.
Zacks·3d ago
News Placeholder
TECH Stock Falls on Q3 Earnings & Revenue Miss, Operating Margin Up
Bio-Techne slips after Q3 EPS miss and revenue decline, despite operating margin expansion and strong growth in key segments.
Zacks·3d ago
News Placeholder
Globus Medical (GMED) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
Get a deeper insight into the potential performance of Globus Medical (GMED) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Zacks·4d ago
News Placeholder
IDEXX Stock Up on Q1 Earnings & Revenue Beat, Margins Rise, '26 View Up
IDXX rides strong on Q1 beats with rising margins; lifts 2026 outlook as diagnostics growth and innovation momentum fuel performance.
Zacks·4d ago
<
1
2
...
>

Latest GMED News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.